Item 1 of 1 (back to results) XMD8-92 A dimethylpyrimido[4,5-b][1,4]benzodiazepin-6-one carrying at C-2 on the pyrimidine ring a [2-ethoxy-4-(4-hydroxypiperidin-1-yl)phenyl]amino substituent. It is an inhibitor of the BMK1 kinase pathway.

Current search: 03. Biological Effects of Specific Chemicals: biochemical uses [CHEBI:52206] > enzyme inhibitor [CHEBI:23924] > protein kinase inhibitor [CHEBI:37699] > XMD8-92 [CHEBI:60325] × Select any link to see items in a related category. more general categories    information about this item 03. Biological Effects of Specific Chemicals  03. Biological Effects of Specific Chemicals  biochemical uses [CHEBI:52206] (3306)   enzyme inhibitor [CHEBI:23924] (825)   protein kinase inhibitor [CHEBI:37699] (69)   XMD8-92 [CHEBI:60325] (1) 08. Chemical Category  08. Chemical Category  main group molecular entity [CHEBI:33579] (25650)   p-block molecular entity [CHEBI:33675] (25343)   carbon group molecular entity [CHEBI:33582] (23847)   organic molecular entity [CHEBI:50860] (23769)   heteroorganic entity [CHEBI:33285] (15197)   organic heterocyclic compound [CHEBI:24532] (5243)   organic heteropolycyclic compound [CHEBI:38166] (2613)   organic heterotricyclic compound [CHEBI:26979] (541)   pyrimidobenzodiazepine [CHEBI:60326] (1)   XMD8-92 [CHEBI:60325] (1)  organic molecule [CHEBI:72695] (11399)   organic cyclic compound [CHEBI:33832] (7633)   organic heterocyclic compound [CHEBI:24532] (5243)   organic heteropolycyclic compound [CHEBI:38166] (2613)   organic heterotricyclic compound [CHEBI:26979] (541)   pyrimidobenzodiazepine [CHEBI:60326] (1)   XMD8-92 [CHEBI:60325] (1)  organic polycyclic compound [CHEBI:51958] (1654)   organic tricyclic compound [CHEBI:51959] (755)   organic heterotricyclic compound [CHEBI:26979] (541)   pyrimidobenzodiazepine [CHEBI:60326] (1)   XMD8-92 [CHEBI:60325] (1)  polyatomic entity [CHEBI:36357] (18777)   molecule [CHEBI:25367] (11520)   cyclic compound [CHEBI:33595] (7817)   polycyclic compound [CHEBI:33635] (4078)   heteropolycyclic compound [CHEBI:33671] (2613)   heterotricyclic compound [CHEBI:36688] (541)   organic heterotricyclic compound [CHEBI:26979] (541)   pyrimidobenzodiazepine [CHEBI:60326] (1)   XMD8-92 [CHEBI:60325] (1)  organic heteropolycyclic compound [CHEBI:38166] (2613)   organic heterotricyclic compound [CHEBI:26979] (541)   pyrimidobenzodiazepine [CHEBI:60326] (1)   XMD8-92 [CHEBI:60325] (1)  organic polycyclic compound [CHEBI:51958] (1654)   organic tricyclic compound [CHEBI:51959] (755)   organic heterotricyclic compound [CHEBI:26979] (541)   pyrimidobenzodiazepine [CHEBI:60326] (1)   XMD8-92 [CHEBI:60325] (1)  organic cyclic compound [CHEBI:33832] (7633)   organic heterocyclic compound [CHEBI:24532] (5243)   organic heteropolycyclic compound [CHEBI:38166] (2613)   organic heterotricyclic compound [CHEBI:26979] (541)   pyrimidobenzodiazepine [CHEBI:60326] (1)   XMD8-92 [CHEBI:60325] (1)  organic polycyclic compound [CHEBI:51958] (1654)   organic tricyclic compound [CHEBI:51959] (755)   organic heterotricyclic compound [CHEBI:26979] (541)   pyrimidobenzodiazepine [CHEBI:60326] (1)   XMD8-92 [CHEBI:60325] (1)  heterocyclic compound [CHEBI:5686] (5275)   organic heterocyclic compound [CHEBI:24532] (5243)   organic heteropolycyclic compound [CHEBI:38166] (2613)   organic heterotricyclic compound [CHEBI:26979] (541)   pyrimidobenzodiazepine [CHEBI:60326] (1)   XMD8-92 [CHEBI:60325] (1)  heteropolycyclic compound [CHEBI:33671] (2613)   heterotricyclic compound [CHEBI:36688] (541)   organic heterotricyclic compound [CHEBI:26979] (541)   pyrimidobenzodiazepine [CHEBI:60326] (1)   XMD8-92 [CHEBI:60325] (1)  organic heteropolycyclic compound [CHEBI:38166] (2613)   organic heterotricyclic compound [CHEBI:26979] (541)   pyrimidobenzodiazepine [CHEBI:60326] (1)   XMD8-92 [CHEBI:60325] (1)  organic molecule [CHEBI:72695] (11399)   organic cyclic compound [CHEBI:33832] (7633)   organic heterocyclic compound [CHEBI:24532] (5243)   organic heteropolycyclic compound [CHEBI:38166] (2613)   organic heterotricyclic compound [CHEBI:26979] (541)   pyrimidobenzodiazepine [CHEBI:60326] (1)   XMD8-92 [CHEBI:60325] (1)  organic polycyclic compound [CHEBI:51958] (1654)   organic tricyclic compound [CHEBI:51959] (755)   organic heterotricyclic compound [CHEBI:26979] (541)   pyrimidobenzodiazepine [CHEBI:60326] (1)   XMD8-92 [CHEBI:60325] (1) ChEBI Compound Accession Identifier:   [CHEBI:60325] ChEBI Compound Description:   A dimethylpyrimido[4,5-b][1,4]benzodiazepin-6-one carrying at C-2 on the pyrimidine ring a [2-ethoxy-4-(4-hydroxypiperidin-1-yl)phenyl]amino substituent. It is an inhibitor of the BMK1 kinase pathway. ChEBI Compound Identification Number:   60325 ChEBI InChI Value:   InChI=1S/C26H30N6O3/c1-4-35-23-15-17(32-13-11-18(33)12-14-32)9-10-20(23)28-26-27-16-22-24(29-26)30(2)21-8-6-5-7-19(21)25(34)31(22)3/h5-10,15-16,18,33H,4,11-14H2,1-3H3,(H,27,28,29) ChEBI InChIKey Value:   QAPAJIZPZGWAND-UHFFFAOYSA-N ChEBI Compound Name:   XMD8-92 ChEBI SMILES Value:   CCOc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C)c2n1)N1CCC(O)CC1 ChEBI Substance ID:   99364975 ChEBI URL:   ChEBI:60325 ChemSpider ID:   26232161 Ontomatica Chemical Accession Key (OnChAKey):   QAPAJIZPZGWAND_UHFFFAOYSA_N_000_000000 PubChem Compound ID:   46843772